Responses
Clinical/translational cancer immunotherapy
Original research
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
